Japan Tobacco to buy Russia cigarette maker


(MENAFN- Gulf Times) Japan Tobacco Inc agreed to buy Russia's Donskoy Tabak for 90bn roubles ($1.6bn), strengthening its leading position in the country as competition from cigarette alternatives erodes its domestic market share.
Donskoy Tabak has a 7% share in Russia, the world's third-largest tobacco market, Japan Tobacco said in a statement yesterday.
The Tokyo-based company already controls about one-third of the cigarette business in Russia, where tax increases and restrictions on smoking in public places have taken a toll.
Japan Tobacco has been grappling with domestic and global headwinds that have impacted the industry's sales and profitability.
Its dominance in the Japanese tobacco market has been challenged as rivals' high-tech products, such as Philip Morris International Inc's IQOS, lure smokers away from cigarettes.
The company said it expects domestic cigarette sales volume to fall almost 17% in 2018.
Masamichi Terabatake, who took over as Japan Tobacco president at the start of the year, said the company would actively pursue deals to expand its share of existing markets while pushing into new ones.
The company, which acquired international rights to the Natural American Spirit brand in 2015, last year snapped up assets in emerging markets like the Philippines, Indonesia and Ethiopia.
The Russian company it's acquiring owns brands such as Donskoy Tabak, Kiss and Play. Its sales totalled $278mn last year, Japan Tobacco said.
The transaction should be completed by the third quarter, Japan Tobacco said.
The deal will be financed with cash and debt and is not expected to affect earnings for this fiscal year.




MENAFN1703201800670000ID1096606099


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.